Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Link opens in a new tab
Search content at Icahn School of Medicine at Mount Sinai
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Pharmacotherapy for post traumatic stress disorder (PTSD).
D. J. Stein
, J. C. Ipser
, S. Seedat
Research output
:
Contribution to journal
›
Review article
›
peer-review
298
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Pharmacotherapy for post traumatic stress disorder (PTSD).'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Posttraumatic Stress Disorder
100%
Pharmacotherapy
100%
Placebo
40%
Confidence Interval
30%
Randomized Controlled Trial
30%
Selective Serotonin Reuptake Inhibitors
30%
Disability
20%
Medication Classes
20%
Comorbid Depression
10%
Symptom Severity
10%
Cochrane Library
10%
Relative Risk
10%
Random Effects Model
10%
Medication Use
10%
Long-term Treatment
10%
MEDLINE
10%
Cochrane Central Register of Controlled Trials
10%
Cochrane
10%
PsycINFO
10%
Trial Quality
10%
Treatment Efficacy
10%
Missing Data
10%
Medication Effects
10%
Continuous Measures
10%
Posttraumatic Stress Disorder Symptom Clusters
10%
Weighted Mean Difference
10%
Placebo Response
10%
Number of Participants
10%
Neurosis
10%
Responder Status
10%
Model Heterogeneity
10%
Medication Response
10%
Long-term Medication
10%
Issue 4
10%
Well Tolerated
10%
Narrative Review
10%
Anxiety-depressive Disorders
10%
Medication Treatment
10%
Trial Data
10%
Number-needed-to-treat
10%
Subgroup Sensitivity Analysis
10%
Nursing and Health Professions
Drug Therapy
100%
Posttraumatic Stress Disorder
100%
Placebo
45%
Confidence Interval
27%
Selective Serotonin Reuptake Inhibitor
27%
Cochrane Library
18%
Base
9%
Long Term Care
9%
PsycINFO
9%
Numbers Needed to Treat
9%
Neurosis
9%
Diseases
9%
Efficacy
9%
Neuroscience
Posttraumatic Stress Disorder
100%
Drug Therapy
100%
Placebo
45%
Randomized Controlled Trial
27%
Selective Serotonin Reuptake Inhibitor
27%
Neuroticism
9%